Monday, 2 March 2020

New trial alert: Hypofractionated whole-pelvis radiation therapy (WPRT) vs. conventionally-fractionated WPRT in prostate cancer

A new trial sponsored, in part by the Canadian Association of Radiation Oncology is seeking to determine "if 5 fractions of external radiation therapy with higher radiation doses per fraction to the pelvis leads to similar results to the standard of care external radiation therapy treatment that is comprised of 25 fractions of external radiation therapy with lower radiation doses per fraction to the pelvis."  The primary outcome of the trial is quality of life with regards to late bowel function, while secondary outcomes include acute urinary and sexual quality of life outcomes.

To learn more about this trial, click here.

No comments:

Post a Comment